Cargando…
Feasibility, Safety, and Tolerance of Mesenchymal Stem Cell Therapy for Obstructive Chronic Lung Allograft Dysfunction
Feasibility, tolerance, and safety of intravenous infusions of allogeneic mesenchymal stem cell (MSC) therapy in lung transplant recipients with bronchiolitis obliterans syndrome (BOS) are not well established. MSCs were manufactured, cryopreserved, transported to our facility, thawed, and infused i...
Autores principales: | Keller, Cesar Ariel, Gonwa, Thomas Arthur, Hodge, David Orel, Hei, Derek Joseph, Centanni, John Michael, Zubair, Abba Chedi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788872/ https://www.ncbi.nlm.nih.gov/pubmed/29322685 http://dx.doi.org/10.1002/sctm.17-0198 |
Ejemplares similares
-
Feasibility and Safety of Low-Dose Mesenchymal Stem Cell Infusion in Lung Transplant Recipients
por: Erasmus, David Brett, et al.
Publicado: (2022) -
A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft Rejection
por: Shi, Ming, et al.
Publicado: (2017) -
Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration
por: Casiraghi, Federica, et al.
Publicado: (2019) -
Genetic polymorphisms of Interleukin-18 are not associated with allograft function in kidney transplant recipients
por: do Nascimento, Wenna Gleyce Araújo, et al.
Publicado: (2014) -
Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome
por: Shaz, Beth H, et al.
Publicado: (2023)